
ASPI
ASP Isotopes Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
10.200
Open
10.200
VWAP
9.38
Vol
8.98M
Mkt Cap
852.95M
Low
8.950
Amount
84.20M
EV/EBITDA(TTM)
--
Total Shares
51.76M
EV
1.00B
EV/OCF(TTM)
--
P/S(TTM)
156.00
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
12.90M
+980.51%
-0.030
-76.92%
6.60M
+506.78%
-0.090
-25%
--
--
-0.050
-79.17%
Estimates Revision
The market is revising No Change the revenue expectations for ASP Isotopes Inc. (ASPI) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 21.31%.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Stock Price
Go Up

+21.31%
In Past 3 Month
2 Analyst Rating
Wall Street analysts forecast ASPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPI is 10.25 USD with a low forecast of 9.50 USD and a high forecast of 11.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 9.280

Low
9.50
Averages
10.25
High
11.00
Current: 9.280

Low
9.50
Averages
10.25
High
11.00
Canaccord
Buy
upgrade
$11
2025-05-21
Reason
Canaccord
Price Target
$11
2025-05-21
upgrade
Buy
Reason
Canaccord raised the firm's price target on ASP Isotopes to $11 from $8.50 and keeps a Buy rating on the shares. The firm said they are positive on the multiple definitive agreements with TerraPower, "related to financing support for the construction of a new uranium enrichment facility capable of producing High Assay Low-Enriched Uranium (HALEU), and the future supply of HALEU to TerraPower, as a customer." Canaccord raised its estimates and they see room for further upside with the announced transaction and management's ability to execute.
Canaccord Genuity
George Gianarikas
Strong Buy
Maintains
$4.5
2024-10-18
Reason
Canaccord Genuity
George Gianarikas
Price Target
$4.5
2024-10-18
Maintains
Strong Buy
Reason
Canaccord Genuity
George Gianarikas
Strong Buy
Initiates
$4.5
2024-10-04
Reason
Canaccord Genuity
George Gianarikas
Price Target
$4.5
2024-10-04
Initiates
Strong Buy
Reason
Canaccord analyst George Gianarikas initiated coverage of ASP Isotopes with a Buy rating and $4.50 price target. "Hidden in the depths of South Africa's sophisticated yet discreet nuclear technology industry, ASP holds significant promise," the analyst tells investors in a research note. The firm says the company could help the West counter Russia's dominance of the uranium supply chain. In addition, ASP's enrichment technology could yield several isotopes that may well advance the market for nuclear medicine and accelerate the adoption of advanced semiconductor technologies, contends Canaccord.
See All Ratings
Valuation Metrics
The current forward P/E ratio for ASP Isotopes Inc (ASPI.O) is -58.53, compared to its 5-year average forward P/E of -17.36. For a more detailed relative valuation and DCF analysis to assess ASP Isotopes Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-17.36
Current PE
-58.53
Overvalued PE
0.51
Undervalued PE
-35.24
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
5.42
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
31.44
Undervalued EV/EBITDA
-20.61
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
12.98
Current PS
17.89
Overvalued PS
23.42
Undervalued PS
2.54
Financials
Annual
Quarterly
FY2025Q2
YoY :
+17.22%
1.20M
Total Revenue
FY2025Q2
YoY :
+60.49%
-11.97M
Operating Profit
FY2025Q2
YoY :
+746.23%
-75.16M
Net Income after Tax
FY2025Q2
YoY :
+329.17%
-1.03
EPS - Diluted
FY2025Q2
YoY :
+25.21%
-9.70M
Free Cash Flow
FY2025Q2
YoY :
+15.93%
47.74
Gross Profit Margin - %
FY2025Q2
-682.82
FCF Margin - %
FY2025Q2
YoY :
+621.91%
-6.27K
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
6.5M
USD
6
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
1,000
Volume
1
6-9
Months
450.0K
Volume
2
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
6.5M
USD
6
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ASPI News & Events
Events Timeline
2025-08-15 (ET)
2025-08-15
08:58:24
ASP Isotopes enters MoU with Fermi America regarding joint venture

2025-08-08 (ET)
2025-08-08
09:04:58
ASP Isotopes announces expected commencement of dual listing on JSE

2025-07-28 (ET)
2025-07-28
08:37:58
ASP Isotopes, IsoBio announces Series Seed funding of IsoBio

Sign Up For More Events
Sign Up For More Events
News
4.5
15:00 PMNASDAQ.COMETF Movers on Friday: REMX and NUKZ
7.5
08-15NewsfilterFermi America™ and ASP Isotopes Join Forces to Secure America's Advanced Reactor Fuel Supply
7.5
08-15PRnewswireFermi America™ and ASP Isotopes Join Forces to Secure America's Advanced Reactor Fuel Supply
Sign Up For More News
People Also Watch

CARE
Carter Bankshares Inc
19.460
USD
0.00%

XPER
Xperi Inc
6.000
USD
-0.66%

GNTY
Guaranty Bancshares Inc
49.140
USD
+0.86%

LE
Lands End Inc
14.360
USD
-1.37%

NIPG
NIP Group Inc
1.997
USD
+5.11%

BKKT
Bakkt Holdings Inc
8.770
USD
+0.92%

GNE
Genie Energy Ltd
15.300
USD
+1.46%

LOVE
Lovesac Co
19.130
USD
+0.84%

EHAB
Enhabit Inc
7.880
USD
-0.51%

LESL
Leslie's Inc
0.332
USD
-3.76%
FAQ

What is ASP Isotopes Inc (ASPI) stock price today?
The current price of ASPI is 9.28 USD — it has decreased -11.91 % in the last trading day.

What is ASP Isotopes Inc (ASPI)'s business?

What is the price predicton of ASPI Stock?

What is ASP Isotopes Inc (ASPI)'s revenue for the last quarter?

What is ASP Isotopes Inc (ASPI)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for ASP Isotopes Inc (ASPI)'s fundamentals?

How many employees does ASP Isotopes Inc (ASPI). have?
